SYDNEY MARVIN: Open Payments
NPI 1124716568 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,864 in 165 payments from 18 companies in 2025. Trend: 2023 $3,306 · 2024 $5,066 · 2025 $4,864
Food & beverage: $3,761Consulting: $820Education: $283
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 6 | $1,158 |
| UCB, Inc. | 16 | $563 |
| Lilly USA, LLC | 10 | $428 |
| Janssen Biotech, Inc. | 13 | $361 |
| Regeneron Healthcare Solutions, Inc. | 15 | $334 |
| ABBVIE INC. | 12 | $274 |
| GENZYME CORPORATION | 15 | $259 |
| Arcutis Biotherapeutics, Inc. | 23 | $252 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $239 |
| Organon LLC | 15 | $221 |
Products named: DUPIXENT, Bimzelx, TREMFYA, EBGLYSS, ANZUPGO, Zoryve, OPZELURA, Sotyktu.
Industry payments across TX — which companies pay providers there.
